Infectious Disease Control

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

- 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa GAITHERSBURG, Md., March 12, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnolog...

2021-03-12 05:04 4701

Largest-ever installation of LightAir Health+

STOCKHOLM, March 11, 2021 /PRNewswire/ -- LightAir has received an order for a large installation of air purifiers and virus inhibitors within its Professional Solutions segment. The American International School ofBucharest has ordered an air purification capacity of approximately100,000 m3/h, w...

2021-03-11 20:50 2452

Zymo Research Receives 510(k) Clearance for its Collection/Transport Device for COVID-19

IRVINE, Calif., March 11, 2021 /PRNewswire/ -- Zymo Research announced today the U.S. Food and Drug Administration (FDA) has cleared itsDNA/RNA Shield™ Collection Tube as a Class II medical device. The FDA's 510(k) clearance allows the product to be used as an In-vitro Diagnostic (IVD) device for...

2021-03-11 14:37 3351

Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs

SHIJIAZHUANG, China, March 11, 2021 /PRNewswire/ -- As an epitome of the Chinese civilization, traditional Chinese medicine or TCM, and western medicine, reinforce each other to protect and improve people's health. Since the outbreak of the COVID-19 pandemic,China has been strengthening the inte...

2021-03-11 13:46 3653

First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic

BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Ni...

2021-03-11 08:00 1450

HKBN Enterprise Solutions Offers Prompt Support to Catering Businesses with PHILIPS UV-C Air Disinfection Device

HONG KONG, March 9, 2021 /PRNewswire/ -- Understanding the special operational needs of catering businesses during COVID, HKBN Enterprise Solutions ("HKBNES") has teamed up with Signify (formerly Philips Lighting) to bring to the market – in particular restaurants and catering premises –PHILIPS U...

2021-03-09 16:29 3299

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...

2021-03-05 04:01 5355

Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service

IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...

2021-03-04 14:33 3985

e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology

* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...

2021-03-03 09:00 3211

BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants

BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...

2021-03-01 21:00 6123

VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections

-  VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. -  The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...

2021-02-24 22:00 3674
1 ... 2930313233

Week's Top Stories